<p>The AE experienced during the study are listed.</p><p><sup>*</sup>Frequency: 1 = Intermittent, 2 = Continuous, 3 = Single Episode.</p>†<p>Relationship to Study Drug: 1 = Related, 2 = Not related.</p><p>Adverse Events (AE).</p
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
Objective: The objective of the study was to analyze the pattern and risk factors of adverse drug re...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
*<p>A treatment-emergent adverse event was defined as an adverse event that was reported on or after...
<p>AE, adverse event.</p><p>Subjects with multiple occurrences of the same event are counted only on...
Incidence of adverse events during on-treatment follow-up and whole study period.</p
<p>Only adverse events recorded in 3 patients or more have been listed in this table. A total of 196...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>*reported as possibly related.</p><p>Adverse events (AEs) during trial period (day 0–182) by vacc...
<p>Studies reporting quantitative data for adverse events (AEs) after ivermectin-albendazole co-admi...
<p>The relationship between the incidence of reported adverse events per number of concomitant medic...
<p>The Safety population includes all subjects who received ≥1 dose of study drug. Subjects with mul...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>Abbreviations: AE = adverse event, FBS = fetal bovine serum, GVHD = graft versus host disease, MR...
This study investigated the occurrence and characteristics of adverse drug reactions (ADR) in our ho...
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
Objective: The objective of the study was to analyze the pattern and risk factors of adverse drug re...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
*<p>A treatment-emergent adverse event was defined as an adverse event that was reported on or after...
<p>AE, adverse event.</p><p>Subjects with multiple occurrences of the same event are counted only on...
Incidence of adverse events during on-treatment follow-up and whole study period.</p
<p>Only adverse events recorded in 3 patients or more have been listed in this table. A total of 196...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>*reported as possibly related.</p><p>Adverse events (AEs) during trial period (day 0–182) by vacc...
<p>Studies reporting quantitative data for adverse events (AEs) after ivermectin-albendazole co-admi...
<p>The relationship between the incidence of reported adverse events per number of concomitant medic...
<p>The Safety population includes all subjects who received ≥1 dose of study drug. Subjects with mul...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>Abbreviations: AE = adverse event, FBS = fetal bovine serum, GVHD = graft versus host disease, MR...
This study investigated the occurrence and characteristics of adverse drug reactions (ADR) in our ho...
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
Objective: The objective of the study was to analyze the pattern and risk factors of adverse drug re...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...